Fraker DL - Search Results

1

Surgery for metastatic neuroendocrine tumors with occult primaries.

Bartlett EK, Roses RE, Gupta M, Shah PK, Shah KK, Zaheer S, Wachtel H, Kelz RR, Karakousis GC, Fraker DL. Bartlett EK, et al. Among authors: fraker dl. J Surg Res. 2013 Sep;184(1):221-7. doi: 10.1016/j.jss.2013.04.008. Epub 2013 Apr 25. J Surg Res. 2013. PMID: 23643298

2

Interferon-beta gene therapy improves survival in an immunocompetent mouse model of carcinomatosis.

Hendren SK, Prabakaran I, Buerk DG, Karakousis G, Feldman M, Spitz F, Menon C, Fraker DL. Hendren SK, et al. Among authors: fraker dl. Surgery. 2004 Apr;135(4):427-36. doi: 10.1016/j.surg.2003.08.015. Surgery. 2004. PMID: 15041967

3

Morbidity and mortality of colorectal carcinoma surgery differs by insurance status.

Kelz RR, Gimotty PA, Polsky D, Norman S, Fraker D, DeMichele A. Kelz RR, et al. Cancer. 2004 Nov 15;101(10):2187-94. doi: 10.1002/cncr.20624. Cancer. 2004. PMID: 15382089 Free article.

4

Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.

Kesmodel SB, Karakousis GC, Botbyl JD, Canter RJ, Lewis RT, Wahl PM, Terhune KP, Alavi A, Elder DE, Ming ME, Guerry D, Gimotty PA, Fraker DL, Czerniecki BJ, Spitz FR. Kesmodel SB, et al. Among authors: fraker dl. Ann Surg Oncol. 2005 Jun;12(6):449-58. doi: 10.1245/ASO.2005.04.027. Epub 2005 Apr 19. Ann Surg Oncol. 2005. PMID: 15864482

5

Predictors of regional nodal disease in patients with thin melanomas.

Karakousis GC, Gimotty PA, Botbyl JD, Kesmodel SB, Elder DE, Elenitsas R, Ming ME, Guerry D, Fraker DL, Czerniecki BJ, Spitz FR. Karakousis GC, et al. Among authors: fraker dl. Ann Surg Oncol. 2006 Apr;13(4):533-41. doi: 10.1245/ASO.2006.05.011. Epub 2006 Mar 7. Ann Surg Oncol. 2006. PMID: 16523360

6

Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients.

Karakousis GC, Gimotty PA, Czerniecki BJ, Elder DE, Elenitsas R, Ming ME, Fraker DL, Guerry D, Spitz FR. Karakousis GC, et al. Among authors: fraker dl. Ann Surg Oncol. 2007 May;14(5):1596-603. doi: 10.1245/s10434-006-9319-y. Epub 2007 Feb 7. Ann Surg Oncol. 2007. PMID: 17285396

7

Interpretation of intra-operative PTH changes in patients with multi-glandular primary hyperparathyroidism (pHPT).

Karakousis GC, Han D, Kelz RR, Nemani D, Karamacharya J, Roses R, Gimotty PA, Fraker DL. Karakousis GC, et al. Among authors: fraker dl. Surgery. 2007 Dec;142(6):845-50; discussion 850.e1-2. doi: 10.1016/j.surg.2007.09.009. Surgery. 2007. PMID: 18063066

8

Analysis of HIF-1a and its regulator, PHD2, in retroperitoneal sarcomas: clinico-pathologic implications.

Huang JH, Lee FS, Pasha TL, Sammel MD, Karakousis G, Xu G, Fraker D, Zhang PJ. Huang JH, et al. Cancer Biol Ther. 2010 Feb;9(4):303-11. doi: 10.4161/cbt.9.4.10744. Epub 2009 Dec 22. Cancer Biol Ther. 2010. PMID: 20026900 Free PMC article.

9

Regional recurrence after lymphadenectomy for clinically evident lymph node metastases from papillary thyroid cancer: a cohort study.

Shah PK, Shah KK, Karakousis GC, Reinke CE, Kelz RR, Fraker DL. Shah PK, et al. Among authors: fraker dl. Ann Surg Oncol. 2012 May;19(5):1453-9. doi: 10.1245/s10434-011-1890-1. Epub 2011 Sep 13. Ann Surg Oncol. 2012. PMID: 21913023

10

Does the presence of thyroid cancer increase the risk of venous thromboembolism in patients undergoing thyroidectomy?

Reinke CE, Hadler RA, Karakousis GC, Fraker DL, Kelz RR. Reinke CE, et al. Among authors: fraker dl. Surgery. 2011 Dec;150(6):1275-85. doi: 10.1016/j.surg.2011.09.040. Surgery. 2011. PMID: 22136851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters